Panel: Policy, Politics, and Pharma: Navigating Uncertainty in a High-Stakes Climate

Session details:

In the current climate, pharmaceutical companies face heightened scrutiny and increased uncertainty regarding the administration’s priorities and policies.  As policymakers advance new regulations—from CMS negotiations to marketing disclosures—the pressure is on commercial and marketing leaders to respond with agility and integrity. This panel will explore how evolving policy dynamics are reshaping the rules of engagement for pharma.  Experts from across the industry will share strategies to navigate today’s complex environment while maintaining trust, brand strength, and meaningful connections with their key customers.